Clinical research status of iridocorneal endothelial syndrome
10.3980/j.issn.1672-5123.2020.8.11
- VernacularTitle:虹膜角膜内皮综合征的临床研究现状
- Author:
Yu-Lin Shi
1
,
2
Author Information
1. Fujian Institute of Ophthalmology
2. Department of Ophthalmology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China
- Publication Type:Review
- Keywords:
iridocorneal endothelial syndrome;
corneal endothelial edema;
iris atrophy;
secondary glaucoma;
keratoplasty
- From:
International Eye Science
2020;20(8):1351-1354
- CountryChina
- Language:Chinese
-
Abstract:
Iridocorneal endothelial(ICE)syndrome presents a group of ocular pathologies mostly characterized by corneal endothelial abnormalities and iris atrophy. Iridocorneal endothelial syndrome is typically a unilateral and generally not involving genetic condition, frequently affecting women in early to middle adulthood. There is no treatment for absence of symptoms in early stages. When complicated with corneal edema and secondary glaucoma, treatment is mainly symptomatic. In this group of diseases, there are many similarities and some differences in their pathogenesis, clinical manifestations and treatment. So far no universal information on these features has been published. Recent clinical studies on iridocorneal endothelial syndrome are reviewed in this paper.
- Full text:202008011.pdf
